Literature DB >> 19447196

Short 5Fr vs long 3Fr pancreatic stents in patients at risk for post-endoscopic retrograde cholangiopancreatography pancreatitis.

Prabhleen Chahal1, Paul R Tarnasky, Bret T Petersen, Mark D Topazian, Michael J Levy, Christopher J Gostout, Todd H Baron.   

Abstract

BACKGROUND & AIMS: Prophylactic placement of pancreatic duct (PD) stents reduces the risk of post-endoscopic retrograde cholangiopancreatography pancreatitis (PEP) in high-risk patients. Some endoscopists prefer longer length, unflanged 3Fr PD stents because they are supposedly more effective and have a higher rate of spontaneous dislodgement; we compared outcomes of patients with these 2 types of stents.
METHODS: Patients at high risk for PEP were randomly assigned to groups given either a straight, 5Fr, 3 cm long, unflanged PD stent (n = 116) or a 3Fr, 8 cm or longer, unflanged PD stent (n = 133). Abdominal radiographs were obtained at 24 hours, 7 days, and 14 days following stent placement to assess spontaneous stent dislodgement. PEP was defined according to consensus criteria.
RESULTS: After 14 days, the spontaneous stent dislodgement rates were 98% for 5Fr stents and 88% for 3Fr stents (P = .0001). PEP occurred in 12% of patients. The incidence of PEP was higher in the 3Fr group (14%) than the 5Fr group (9%), although this difference was not statistically significant (P = .3). Placement failure did not occur in any patients in the 5Fr stent group, but did occur in 11 of the 133 patients in the 3Fr stent group (P = .0003).
CONCLUSIONS: Among patients at high-risk for PEP, the spontaneous dislodgement rate of unflanged, short-length, 5Fr PD stents is significantly higher than for unflanged, long-length, 3Fr stents. This decreases the need for endoscopic removal. A higher rate of PD stent placement failure and PEP was observed in patients with 3Fr stents. To view this article's video abstract, go to the AGA's YouTube Channel.

Entities:  

Mesh:

Year:  2009        PMID: 19447196     DOI: 10.1016/j.cgh.2009.05.002

Source DB:  PubMed          Journal:  Clin Gastroenterol Hepatol        ISSN: 1542-3565            Impact factor:   11.382


  30 in total

1.  Letter in response to the recently published study: prophylactic pancreatic stents: does size matter? A comparison of 4-Fr and 5-Fr stents in reference to post-ERCP pancreatitis and migration rate.

Authors:  Prabhleen Chahal; Todd H Baron
Journal:  Dig Dis Sci       Date:  2012-04       Impact factor: 3.199

Review 2.  Endoscopic complications--avoidance and management.

Authors:  Daniel Blero; Jacques Devière
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2012-02-14       Impact factor: 46.802

3.  Post-endoscopic retrograde cholangiopancreatography complications: How can they be avoided?

Authors:  Juan J Vila; Everson L A Artifon; Jose Pinhata Otoch
Journal:  World J Gastrointest Endosc       Date:  2012-06-16

4.  The impact of prophylactic pancreatic stenting on post-ERCP pancreatitis: A nationwide, register-based study.

Authors:  Greger Olsson; Jeanne Lübbe; Urban Arnelo; Eduard Jonas; Björn Törnqvist; Lars Lundell; Lars Enochsson
Journal:  United European Gastroenterol J       Date:  2016-07-08       Impact factor: 4.623

5.  Complications of ERCP.

Authors:  Nalini M Guda; Duvvuru Nageshwar Reddy; Ajay Kumar
Journal:  Indian J Gastroenterol       Date:  2013-09-17

Review 6.  Clinical practice guideline for post-ERCP pancreatitis.

Authors:  Tetsuya Mine; Toshio Morizane; Yoshiaki Kawaguchi; Ryukichi Akashi; Keiji Hanada; Tetsuhide Ito; Atsushi Kanno; Mitsuhiro Kida; Hiroyuki Miyagawa; Taketo Yamaguchi; Toshihiko Mayumi; Yoshifumi Takeyama; Tooru Shimosegawa
Journal:  J Gastroenterol       Date:  2017-06-26       Impact factor: 7.527

Review 7.  Preventing post-endoscopic retrograde cholangiopancreatography pancreatitis: what can be done?

Authors:  Goran Hauser; Marko Milosevic; Davor Stimac; Enver Zerem; Predrag Jovanović; Ivana Blazevic
Journal:  World J Gastroenterol       Date:  2015-01-28       Impact factor: 5.742

8.  Prophylactic pancreatic stents: does size matter? A comparison of 4-Fr and 5-Fr stents in reference to post-ERCP pancreatitis and migration rate.

Authors:  Albert Pahk; Johanne Rigaux; Vijay Poreddy; Joan Smith; Firas Al-Kawas
Journal:  Dig Dis Sci       Date:  2011-04-13       Impact factor: 3.199

9.  Impact of pancreatic stent caliber on post-endoscopic retrograde cholangiopancreatogram pancreatitis rates in patients with confirmed sphincter of Oddi dysfunction.

Authors:  Jayapal Ramesh; Hwasoon Kim; Kartika Reddy; Shyam Varadarajulu; C Mel Wilcox
Journal:  J Gastroenterol Hepatol       Date:  2014       Impact factor: 4.029

10.  The future developments in endoscopy.

Authors:  Adam Haycock; Kofi W Oppong
Journal:  Frontline Gastroenterol       Date:  2012-05-31
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.